Heghine Khachatryan: Lupus Anticoagulant – An Old Concept Revisited with New Mechanistic Insight
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from Nicola Pozzi on LinkedIn:
“Lupus anticoagulant: an old concept revisited with new mechanistic insight
Recent reflections by Nicola Pozzi remind us that some of the most established concepts in hemostasis and thrombosis still warrant critical re-examination.
In collaboration with Vittorio Pengo, this work revisits lupus anticoagulant from both a historical and mechanistic perspective, integrating emerging insights on antiprothrombin antibodies that have accumulated over recent years.
Why this matters
• Lupus anticoagulant remains a cornerstone laboratory criterion in the diagnosis of antiphospholipid syndrome
• Current testing strategies do not always reflect the underlying biological mechanisms
• New mechanistic data challenge how we interpret and even define what we measure in routine coagulation assays
-This raises an important question:
Is it time to reconsider—and potentially rewrite—parts of our coagulation textbooks?
Progress in science is driven by precisely these moments, when well-established paradigms are revisited in light of robust experimental evidence. Understanding what we measure, why we measure it, and what it truly represents biologically is essential for advancing both diagnostics and patient care.
-Lupus anticoagulant and antiprothrombin antibodies: embracing the future
Journal of Thrombosis and Haemostasis”
Quoting Nicola Pozzi‘s post:
“Hematologists and coagulation enthusiasts—this one’s for you!
Lupus anticoagulant: What is it? How do we measure it? Why does it matter for Antiphospholipid Syndrome (APS)?
Vittorio Pengo and I revisit this highly debated topic with a historical perspective, and share novel mechanistic insights we uncovered in recent years that could reshape how we understand and test for lupus anticoagulant.
Could it be time to rewrite the coagulation textbook? Time (and good science) will tell…”
Title: Lupus anticoagulant and antiprothrombin antibodies: embracing the future
Authors: Vittorio Pengo, Nicola Pozzi
Read also: Danny Hsu and Nicola Pozzi on “Tetra-Positive” APS
-
Apr 16, 2026, 18:27RPTH Journal: Are We Underestimating VTE After PanNET Surgery?
-
Apr 16, 2026, 16:10Hamid Noori: Etiological Classification of Anemia Understanding the Root Cause
-
Apr 16, 2026, 15:29Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis
-
Apr 16, 2026, 15:23Ifeanyichukwu Ifechidere: Argatroban – Its ‘Rescue Mission’ in Heparin-Induced Thrombocytopenia
-
Apr 16, 2026, 14:58Early Diagnosis Can Change Everything in Hemophilia Care – WFH
-
Apr 16, 2026, 14:05Saleh Shamse Basha: When Platelet Counts Mislead, The PLT-F Becomes Critical
-
Apr 16, 2026, 13:44Maha Othman: Celebrating National Medical Laboratory Week in Canada
-
Apr 16, 2026, 13:42Megan Adediran: How Much of What You Know About Hemophilia Is True?
-
Apr 16, 2026, 13:35Priya Singh: How to Write the Discussion of a Research Paper